BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30982172)

  • 1. Role of early and aggressive post-operative radiation therapy in improving outcome for pediatric central nervous system atypical teratoid/rhabdoid tumor.
    Yang WC; Yen HJ; Liang ML; Chen HH; Lee YY; Wong TT; Hu YW; Chen YW
    Childs Nerv Syst; 2019 Jun; 35(6):1013-1020. PubMed ID: 30982172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overall Survival of Primary Intracranial Atypical Teratoid Rhabdoid Tumor Following Multimodal Treatment: A Pooled Analysis of Individual Patient Data.
    Ma XJ; Li D; Wang L; Hao SY; Zhang LW; Zhang JT; Wu Z
    Neurosurg Rev; 2020 Feb; 43(1):281-292. PubMed ID: 30535934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor.
    Zimmerman MA; Goumnerova LC; Proctor M; Scott RM; Marcus K; Pomeroy SL; Turner CD; Chi SN; Chordas C; Kieran MW
    J Neurooncol; 2005 Mar; 72(1):77-84. PubMed ID: 15803379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors.
    Gardner SL; Asgharzadeh S; Green A; Horn B; McCowage G; Finlay J
    Pediatr Blood Cancer; 2008 Aug; 51(2):235-40. PubMed ID: 18381756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience.
    Zaky W; Dhall G; Ji L; Haley K; Allen J; Atlas M; Bertolone S; Cornelius A; Gardner S; Patel R; Pradhan K; Shen V; Thompson S; Torkildson J; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2014 Jan; 61(1):95-101. PubMed ID: 23934933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequencing of local therapy affects the pattern of treatment failure and survival in children with atypical teratoid rhabdoid tumors of the central nervous system.
    Pai Panandiker AS; Merchant TE; Beltran C; Wu S; Sharma S; Boop FA; Jenkins JJ; Helton KJ; Wright KD; Broniscer A; Kun LE; Gajjar A
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1756-63. PubMed ID: 21601374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry.
    Hilden JM; Meerbaum S; Burger P; Finlay J; Janss A; Scheithauer BW; Walter AW; Rorke LB; Biegel JA
    J Clin Oncol; 2004 Jul; 22(14):2877-84. PubMed ID: 15254056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333.
    Reddy AT; Strother DR; Judkins AR; Burger PC; Pollack IF; Krailo MD; Buxton AB; Williams-Hughes C; Fouladi M; Mahajan A; Merchant TE; Ho B; Mazewski CM; Lewis VA; Gajjar A; Vezina LG; Booth TN; Parsons KW; Poss VL; Zhou T; Biegel JA; Huang A
    J Clin Oncol; 2020 Apr; 38(11):1175-1185. PubMed ID: 32105509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimodality therapy for atypical teratoid/rhabdoid tumor is associated with improved overall survival: A surveillance, epidemiology, and end results analysis.
    Quinn TJ; Almahariq MF; Siddiqui ZA; Thompson AB; Hamstra DA; Kabolizadeh P; Gowans KL; Chen PY
    Pediatr Blood Cancer; 2019 Dec; 66(12):e27969. PubMed ID: 31464041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study.
    Dufour C; Beaugrand A; Le Deley MC; Bourdeaut F; André N; Leblond P; Bertozzi AI; Frappaz D; Rialland X; Fouyssac F; Edan C; Grill J; Quidot M; Varlet P
    Cancer; 2012 Aug; 118(15):3812-21. PubMed ID: 22180295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical teratoid/rhabdoid tumors of the central nervous system: management and outcomes.
    Chen ML; McComb JG; Krieger MD
    Neurosurg Focus; 2005 Jun; 18(6A):E8. PubMed ID: 16048294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.
    Tekautz TM; Fuller CE; Blaney S; Fouladi M; Broniscer A; Merchant TE; Krasin M; Dalton J; Hale G; Kun LE; Wallace D; Gilbertson RJ; Gajjar A
    J Clin Oncol; 2005 Mar; 23(7):1491-9. PubMed ID: 15735125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal treatments combined with gamma knife surgery for primary atypical teratoid/rhabdoid tumor of the central nervous system: a single-institute experience of 18 patients.
    Ren YM; Wu X; You C; Zhang YK; Li Q; Ju Y
    Childs Nerv Syst; 2018 Apr; 34(4):627-638. PubMed ID: 29218405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical teratoid rhabdoid tumors of the posterior fossa in children.
    DiPatri AJ; Sredni ST; Grahovac G; Tomita T
    Childs Nerv Syst; 2015 Oct; 31(10):1717-28. PubMed ID: 26351225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB).
    Benesch M; Bartelheim K; Fleischhack G; Gruhn B; Schlegel PG; Witt O; Stachel KD; Hauch H; Urban C; Quehenberger F; Massimino M; Pietsch T; Hasselblatt M; Giangaspero F; Kordes U; Schneppenheim R; Hauser P; Klingebiel T; Frühwald MC
    Bone Marrow Transplant; 2014 Mar; 49(3):370-5. PubMed ID: 24419520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-Analysis of Treatment Modalities in Metastatic Atypical Teratoid/Rhabdoid Tumors in Children.
    Underiner RM; Eltobgy M; Stanek JR; Finlay JL; AbdelBaki MS
    Pediatr Neurol; 2020 Jul; 108():106-112. PubMed ID: 32402552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous system.
    McGovern SL; Okcu MF; Munsell MF; Kumbalasseriyil N; Grosshans DR; McAleer MF; Chintagumpala M; Khatua S; Mahajan A
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1143-52. PubMed ID: 25311260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Influencing Survival of Children with Atypical Teratoid/Rhabdoid Tumors: A Single-Institute Experience in a Developing Country.
    Rao SJB; Konar SK; Shukla D; Bhat DI; Beniwal M; Rao KVLN; Nandeesh BN; Devi BI
    World Neurosurg; 2019 Sep; 129():e264-e272. PubMed ID: 31128308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal therapy in children and adolescents with newly diagnosed atypical teratoid rhabdoid tumor: individual pooled data analysis and review of the literature.
    Schrey D; Carceller Lechón F; Malietzis G; Moreno L; Dufour C; Chi S; Lafay-Cousin L; von Hoff K; Athanasiou T; Marshall LV; Zacharoulis S
    J Neurooncol; 2016 Jan; 126(1):81-90. PubMed ID: 26608522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of atypical teratoid rhabdoid tumors (AT/RT) treated with multimodal therapy protocols. Report of our series.
    Valencia-Moya A; González-García L; Ros-López B; Acha-García T; Weil-Lara B; Obando-Pacheco P; Arráez-Sánchez MÁ
    Neurocirugia (Astur); 2016; 27(2):87-94. PubMed ID: 25900785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.